schliessen

Filtern

 

Bibliotheken

Angiotensin II receptor antagonist reduces urinary liver-type fatty acid-binding protein levels in patients with diabetic nephropathy and chronic renal failure

Byline: T. Nakamura (1), T. Sugaya (2), H. Koide (3) Author Affiliation: (1) Department of Medicine, Shinmatsudo Central General Hospital, Chiba, Japan (2) Research Unit for Organ Regeneration, Riken Kobe Institute, Hyogo, Japan (3) Department of Medicine, Koto Hospital, 6-8-5 Ojima, Koto-ku, Tokyo,... Full description

Journal Title: Diabetologia 2007, Vol.50 (2), p.490-492
Main Author: NAKAMURA, T
Other Authors: SUGAYA, T , KOIDE, H
Format: Electronic Article Electronic Article
Language: English
Subjects:
Publisher: Berlin: Springer
ID: ISSN: 0012-186X
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_proquest_miscellaneous_68418273
title: Angiotensin II receptor antagonist reduces urinary liver-type fatty acid-binding protein levels in patients with diabetic nephropathy and chronic renal failure
format: Article
creator:
  • NAKAMURA, T
  • SUGAYA, T
  • KOIDE, H
subjects:
  • Angiotensin
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors - therapeutic use
  • Associated diseases and complications
  • Benzimidazoles - therapeutic use
  • Benzoates - therapeutic use
  • Biological and medical sciences
  • Care and treatment
  • Chronic kidney failure
  • Creatinine - blood
  • Diabetes. Impaired glucose tolerance
  • Diabetic nephropathies
  • Diabetic Nephropathies - drug therapy
  • Diabetic Nephropathies - urine
  • Endocrine pancreas. Apud cells (diseases)
  • Endocrinopathies
  • Fatty Acid-Binding Proteins - urine
  • Fatty acids
  • Gastroenterology. Liver. Pancreas. Abdomen
  • Glomerular Filtration Rate
  • Humans
  • Kidney Failure, Chronic - drug therapy
  • Kidney Failure, Chronic - prevention & control
  • Kidney Failure, Chronic - urine
  • Kidneys
  • Liver. Biliary tract. Portal circulation. Exocrine pancreas
  • Medical sciences
  • Nephrology. Urinary tract diseases
  • Nephropathies. Renovascular diseases. Renal failure
  • Other diseases. Semiology
  • Protein binding
  • Proteins
  • Renal failure
  • Urinary system involvement in other diseases. Miscellaneous
ispartof: Diabetologia, 2007, Vol.50 (2), p.490-492
description: Byline: T. Nakamura (1), T. Sugaya (2), H. Koide (3) Author Affiliation: (1) Department of Medicine, Shinmatsudo Central General Hospital, Chiba, Japan (2) Research Unit for Organ Regeneration, Riken Kobe Institute, Hyogo, Japan (3) Department of Medicine, Koto Hospital, 6-8-5 Ojima, Koto-ku, Tokyo, 136-0072, Japan Article History: Registration Date: 13/11/2006 Received Date: 25/07/2006 Accepted Date: 01/11/2006 Online Date: 15/12/2006
language: eng
source:
identifier: ISSN: 0012-186X
fulltext: no_fulltext
issn:
  • 0012-186X
  • 1432-0428
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.1510806
LOCALfalse
PrimoNMBib
record
control
sourceidgale_proqu
recordidTN_cdi_proquest_miscellaneous_68418273
sourceformatXML
sourcesystemPC
galeidA328367409
sourcerecordidA328367409
originalsourceidFETCH-LOGICAL-1537t-c405bcf28e068b58c1777e375784c036a5842f575261e40de128a74f91be53d60
addsrcrecordideNqNksGKFDEQhhtR3HH1AbxIUPTWa9JJOpnjsOzqwIIXBW8hna6eyZJJt0l6ZZ7GV7WGGVhdZJE6JKl89adI_VX1mtELRqn6mClljawpbWsqhazFk2rBBG9qKhr9tFocrmum2-9n1YucbymlXIr2eXXGFAZvxaL6tYobPxaI2UeyXpMEDqYyJmJjsZsx-lww188OMpmTjzbtSfB3kOqyn4AMtpQ9sc73dedj7-OGTAnlUCzAHYRMcDfZ4iGWTH76siW9tx0U70iEaZtGvNyiQuyJw1PEfIJoAyr7MCd4WT0bbMjw6rSeV9-ur75efq5vvnxaX65uaia5KrUTVHZuaDTQVndSO6aUAq6k0sJR3lqpRTNIJZuWgaA9sEZbJYYl60DyvqXn1YejLrb_Y4ZczM5nByHYCOOcTasF043iCL59AN6Oc8KOs2kY10JxflB7d4Q2NoDxcRhLsu6gaFa80bxVgi4fpZhUTOOIJFIX_6Aweth5N0YYPOb_kv2vgj9fYMcCl8acEwxmSn6HkzaMmoPRzNFoBo1mDkYzAmvenL5h7nbQ31ecnIXA-xNgs7NhSDY6n-85LcSSaYWcevC48wUNM0bs2odHWvgNeinrmQ
sourcetypeAggregation Database
isCDItrue
recordtypearticle
pqid213847336
display
typearticle
titleAngiotensin II receptor antagonist reduces urinary liver-type fatty acid-binding protein levels in patients with diabetic nephropathy and chronic renal failure
creatorNAKAMURA, T ; SUGAYA, T ; KOIDE, H
creatorcontribNAKAMURA, T ; SUGAYA, T ; KOIDE, H
descriptionByline: T. Nakamura (1), T. Sugaya (2), H. Koide (3) Author Affiliation: (1) Department of Medicine, Shinmatsudo Central General Hospital, Chiba, Japan (2) Research Unit for Organ Regeneration, Riken Kobe Institute, Hyogo, Japan (3) Department of Medicine, Koto Hospital, 6-8-5 Ojima, Koto-ku, Tokyo, 136-0072, Japan Article History: Registration Date: 13/11/2006 Received Date: 25/07/2006 Accepted Date: 01/11/2006 Online Date: 15/12/2006
identifier
0ISSN: 0012-186X
1EISSN: 1432-0428
2DOI: 10.1007/s00125-006-0545-4
3PMID: 17171364
languageeng
publisherBerlin: Springer
subjectAngiotensin ; Angiotensin Receptor Antagonists ; Angiotensin-Converting Enzyme Inhibitors - therapeutic use ; Associated diseases and complications ; Benzimidazoles - therapeutic use ; Benzoates - therapeutic use ; Biological and medical sciences ; Care and treatment ; Chronic kidney failure ; Creatinine - blood ; Diabetes. Impaired glucose tolerance ; Diabetic nephropathies ; Diabetic Nephropathies - drug therapy ; Diabetic Nephropathies - urine ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Fatty Acid-Binding Proteins - urine ; Fatty acids ; Gastroenterology. Liver. Pancreas. Abdomen ; Glomerular Filtration Rate ; Humans ; Kidney Failure, Chronic - drug therapy ; Kidney Failure, Chronic - prevention & control ; Kidney Failure, Chronic - urine ; Kidneys ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; Medical sciences ; Nephrology. Urinary tract diseases ; Nephropathies. Renovascular diseases. Renal failure ; Other diseases. Semiology ; Protein binding ; Proteins ; Renal failure ; Urinary system involvement in other diseases. Miscellaneous
ispartofDiabetologia, 2007, Vol.50 (2), p.490-492
rights
02007 INIST-CNRS
1COPYRIGHT 2007 Springer
2Copyright National Library of Medicine - MEDLINE Abstracts Feb 2007
lds50peer_reviewed
oafree_for_read
citedbyFETCH-LOGICAL-1537t-c405bcf28e068b58c1777e375784c036a5842f575261e40de128a74f91be53d60
citesFETCH-LOGICAL-1537t-c405bcf28e068b58c1777e375784c036a5842f575261e40de128a74f91be53d60
links
openurl$$Topenurl_article
thumbnail$$Usyndetics_thumb_exl
backlink
0$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18449187$$DView record in Pascal Francis
1$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17171364$$D View this record in MEDLINE/PubMed
search
creatorcontrib
0NAKAMURA, T
1SUGAYA, T
2KOIDE, H
title
0Angiotensin II receptor antagonist reduces urinary liver-type fatty acid-binding protein levels in patients with diabetic nephropathy and chronic renal failure
1Diabetologia
addtitleDiabetologia
descriptionByline: T. Nakamura (1), T. Sugaya (2), H. Koide (3) Author Affiliation: (1) Department of Medicine, Shinmatsudo Central General Hospital, Chiba, Japan (2) Research Unit for Organ Regeneration, Riken Kobe Institute, Hyogo, Japan (3) Department of Medicine, Koto Hospital, 6-8-5 Ojima, Koto-ku, Tokyo, 136-0072, Japan Article History: Registration Date: 13/11/2006 Received Date: 25/07/2006 Accepted Date: 01/11/2006 Online Date: 15/12/2006
subject
0Angiotensin
1Angiotensin Receptor Antagonists
2Angiotensin-Converting Enzyme Inhibitors - therapeutic use
3Associated diseases and complications
4Benzimidazoles - therapeutic use
5Benzoates - therapeutic use
6Biological and medical sciences
7Care and treatment
8Chronic kidney failure
9Creatinine - blood
10Diabetes. Impaired glucose tolerance
11Diabetic nephropathies
12Diabetic Nephropathies - drug therapy
13Diabetic Nephropathies - urine
14Endocrine pancreas. Apud cells (diseases)
15Endocrinopathies
16Fatty Acid-Binding Proteins - urine
17Fatty acids
18Gastroenterology. Liver. Pancreas. Abdomen
19Glomerular Filtration Rate
20Humans
21Kidney Failure, Chronic - drug therapy
22Kidney Failure, Chronic - prevention & control
23Kidney Failure, Chronic - urine
24Kidneys
25Liver. Biliary tract. Portal circulation. Exocrine pancreas
26Medical sciences
27Nephrology. Urinary tract diseases
28Nephropathies. Renovascular diseases. Renal failure
29Other diseases. Semiology
30Protein binding
31Proteins
32Renal failure
33Urinary system involvement in other diseases. Miscellaneous
issn
00012-186X
11432-0428
fulltextfalse
rsrctypearticle
creationdate2007
recordtypearticle
recordideNqNksGKFDEQhhtR3HH1AbxIUPTWa9JJOpnjsOzqwIIXBW8hna6eyZJJt0l6ZZ7GV7WGGVhdZJE6JKl89adI_VX1mtELRqn6mClljawpbWsqhazFk2rBBG9qKhr9tFocrmum2-9n1YucbymlXIr2eXXGFAZvxaL6tYobPxaI2UeyXpMEDqYyJmJjsZsx-lww188OMpmTjzbtSfB3kOqyn4AMtpQ9sc73dedj7-OGTAnlUCzAHYRMcDfZ4iGWTH76siW9tx0U70iEaZtGvNyiQuyJw1PEfIJoAyr7MCd4WT0bbMjw6rSeV9-ur75efq5vvnxaX65uaia5KrUTVHZuaDTQVndSO6aUAq6k0sJR3lqpRTNIJZuWgaA9sEZbJYYl60DyvqXn1YejLrb_Y4ZczM5nByHYCOOcTasF043iCL59AN6Oc8KOs2kY10JxflB7d4Q2NoDxcRhLsu6gaFa80bxVgi4fpZhUTOOIJFIX_6Aweth5N0YYPOb_kv2vgj9fYMcCl8acEwxmSn6HkzaMmoPRzNFoBo1mDkYzAmvenL5h7nbQ31ecnIXA-xNgs7NhSDY6n-85LcSSaYWcevC48wUNM0bs2odHWvgNeinrmQ
startdate2007
enddate2007
creator
0NAKAMURA, T
1SUGAYA, T
2KOIDE, H
general
0Springer
1Springer Nature B.V
scope
0IQODW
1CGR
2CUY
3CVF
4ECM
5EIF
6NPM
7AAYXX
8CITATION
9BSHEE
107T5
11H94
12K9.
137X8
sort
creationdate2007
titleAngiotensin II receptor antagonist reduces urinary liver-type fatty acid-binding protein levels in patients with diabetic nephropathy and chronic renal failure
authorNAKAMURA, T ; SUGAYA, T ; KOIDE, H
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-1537t-c405bcf28e068b58c1777e375784c036a5842f575261e40de128a74f91be53d60
rsrctypearticles
prefilterarticles
languageeng
creationdate2007
topic
0Angiotensin
1Angiotensin Receptor Antagonists
2Angiotensin-Converting Enzyme Inhibitors - therapeutic use
3Associated diseases and complications
4Benzimidazoles - therapeutic use
5Benzoates - therapeutic use
6Biological and medical sciences
7Care and treatment
8Chronic kidney failure
9Creatinine - blood
10Diabetes. Impaired glucose tolerance
11Diabetic nephropathies
12Diabetic Nephropathies - drug therapy
13Diabetic Nephropathies - urine
14Endocrine pancreas. Apud cells (diseases)
15Endocrinopathies
16Fatty Acid-Binding Proteins - urine
17Fatty acids
18Gastroenterology. Liver. Pancreas. Abdomen
19Glomerular Filtration Rate
20Humans
21Kidney Failure, Chronic - drug therapy
22Kidney Failure, Chronic - prevention & control
23Kidney Failure, Chronic - urine
24Kidneys
25Liver. Biliary tract. Portal circulation. Exocrine pancreas
26Medical sciences
27Nephrology. Urinary tract diseases
28Nephropathies. Renovascular diseases. Renal failure
29Other diseases. Semiology
30Protein binding
31Proteins
32Renal failure
33Urinary system involvement in other diseases. Miscellaneous
toplevelpeer_reviewed
creatorcontrib
0NAKAMURA, T
1SUGAYA, T
2KOIDE, H
collection
0Pascal-Francis
1Medline
2MEDLINE
3MEDLINE (Ovid)
4MEDLINE
5MEDLINE
6PubMed
7CrossRef
8Academic OneFile (A&I only)
9Immunology Abstracts
10AIDS and Cancer Research Abstracts
11ProQuest Health & Medical Complete (Alumni)
12MEDLINE - Academic
jtitleDiabetologia
delivery
delcategoryRemote Search Resource
fulltextno_fulltext
addata
au
0NAKAMURA, T
1SUGAYA, T
2KOIDE, H
formatjournal
genrearticle
ristypeJOUR
atitleAngiotensin II receptor antagonist reduces urinary liver-type fatty acid-binding protein levels in patients with diabetic nephropathy and chronic renal failure
jtitleDiabetologia
addtitleDiabetologia
date2007
risdate2007
volume50
issue2
spage490
epage492
pages490-492
issn0012-186X
eissn1432-0428
abstractByline: T. Nakamura (1), T. Sugaya (2), H. Koide (3) Author Affiliation: (1) Department of Medicine, Shinmatsudo Central General Hospital, Chiba, Japan (2) Research Unit for Organ Regeneration, Riken Kobe Institute, Hyogo, Japan (3) Department of Medicine, Koto Hospital, 6-8-5 Ojima, Koto-ku, Tokyo, 136-0072, Japan Article History: Registration Date: 13/11/2006 Received Date: 25/07/2006 Accepted Date: 01/11/2006 Online Date: 15/12/2006
copBerlin
pubSpringer
pmid17171364
doi10.1007/s00125-006-0545-4
oafree_for_read